CLINICAL_TRIALS
trial_result
· 2020-01-27
Clinical Trial Update: A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent. [Phase 2]
Summary
Phase 2 study of RO4607381 in patients with coronary heart disease or CHD risk equivalents has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Coronary Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-01-27